🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of the Role of Incisura Biopsy in the Staging of Chronic Gastritis

Recruitingn/aAges 18 Years - anyAllClinical Hospital Colentina
NCT05744596 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective multicenter study investigates the added benefit of incisura biopsy to correct identification of patients with high-risk chronic gastritis (OLGA stages III-IV). It compares a biopsy protocol with and without a single incisura biopsy in a non-inferiority design. Anonymized photo and videodocumentation according to institution practices will constitute a databank for lesion recognition, quality improvement, and potential AI development.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * indication to perform upper GI endoscopy for diagnosis or surveillance Exclusion Criteria: * lack of informed consent, previously diagnosed advanced gastric cancer, incomplete endoscopy, surgically altered stomach
💊

What it tests

  • Incisura biopsy analysis
📍

Where

2 sites
IPO Porto
Porto, Portugal
Colentina Clinical Hospital
Bucharest, Romania
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy